Structural Analysis of the Allocation Limit and Basic Credit Mechanisms in Maryland Research and Development Tax Incentives

The Maryland Basic Credit Cap refers to the annual statutory limit on the total volume of tax credits the Department of Commerce can approve for foundational research expenses. It ensures fiscal control by partitioning a $12 million total fund into specific allocations of $8.5 million for general corporations and $3.5 million for small businesses, utilizing a proration mechanism when applications exceed these amounts.1

Conceptual Framework of the Maryland Allocation Limit

The Maryland Research and Development Tax Credit program serves as a critical fiscal instrument designed to catalyze innovation within the state’s burgeoning technology, life sciences, and manufacturing sectors. At its core, the program is governed by a rigid “Allocation Limit,” a concept historically entwined with the “Basic Credit Cap.” To understand this mechanism, one must first distinguish between the statutory credit rate and the effective credit rate. While the law permits a credit equal to 10% of qualified research expenses exceeding a calculated base amount, the state does not operate an open-ended entitlement program.1 Instead, the General Assembly establishes a fixed pool of capital—currently $12 million—to be distributed among all qualifying applicants.1

The “Basic Credit” was once a specific tier of this program, offering a 3% return on expenses that did not exceed a company’s historical spending base. However, legislative shifts in 2021 effectively consolidated the program around what was formerly known as the “Growth Credit” model, while retaining the overarching logic of capped allocations.4 This cap functions as a macro-economic throttle, allowing the state to encourage R&D activity without exposing the general fund to unpredictable revenue volatility. For the business executive or tax professional, the cap represents a significant variable in financial modeling; because the total amount of requested credits almost always exceeds the available funds, the final value of a company’s credit is subject to a proportional reduction known as proration.1

This allocation system creates a unique administrative environment. Unlike federal R&D credits under Internal Revenue Code § 41, which are generally available to all who meet the criteria, Maryland’s credit is “certified”.1 This means that eligibility is the first hurdle, but the allocation limit is the final arbiter of value. The Department of Commerce acts as the primary administrator, receiving applications, verifying expenditures, and applying the mathematical proration required to fit the state’s multi-billion dollar R&D economy into a $12 million container.1

Legislative History and the Repeal of the Dual-Tier System

The current structure of the Maryland R&D tax credit is the result of decades of refinement, most notably influenced by the 2021 legislative session. Historically, the program was bifurcated to reward both foundational research and incremental growth. Under the pre-2021 statutes, Maryland offered two distinct credits: a “Basic R&D Tax Credit” equal to 3% of expenses up to the base amount, and a “Growth R&D Tax Credit” equal to 10% of expenses exceeding the base amount.6

The dual-tier system was intended to provide a floor of support for consistent R&D spenders while offering a higher incentive for those scaling their operations. However, this structure proved administratively cumbersome. Each tier had its own separate funding cap, and the proration rates between the Basic and Growth buckets often diverged wildly, leading to inequitable outcomes for companies with similar spending profiles.6 In tax year 2016, for example, the Basic credit was oversubscribed six-fold, while the Growth credit was oversubscribed 8.5 times, resulting in effective rates that were a mere fraction of the statutory targets.6

Senate Bill 196, enacted as Chapter 114 of the Acts of 2021, overhauled this architecture. The legislature opted to repeal the 3% Basic Credit entirely, focusing the state’s resources on the 10% Growth model.3 This change was not merely a simplification of math; it represented a policy shift toward rewarding “new” or “increased” research activity rather than sustaining the status quo. By consolidating the funding into a single $12 million pool—while maintaining a specific carve-out for small businesses—the state aimed to mitigate the severe proration that had historically diluted the credit’s impact.3

1

Statutory Framework: Maryland Code Tax-General § 10-721

The governing law for the allocation limit is codified in Maryland Code, Tax-General Article, § 10-721. This statute outlines the specific duties of the Department of Commerce in certifying the credits and the Comptroller in administering the claims. The law establishes the “Research and Development Tax Credit Program” with the explicitly stated purpose of fostering increased research activities and expenditures within the state boundaries.11

The $12 Million Ceiling

Under § 10-721(c)(2), the total amount of credits approved by the Department in any calendar year is capped at $12,000,000. This is a non-discretionary limit; the Department does not have the authority to exceed this amount, even if the total volume of qualified research performed in Maryland reaches billions of dollars.11 The statute further requires that this $12 million be subdivided to protect smaller enterprises from being crowded out by multinational corporations with vast R&D budgets.

Partitioning the Allocation: The Two-Bucket System

The law mandates a specific split of the total funds:

1. Small Business Reserve: Exactly $3,500,000 is reserved for applicants defined as small businesses.11
2. General Allocation: The remaining $8,500,000 is allocated for all other applicants, typically larger C-corporations and established technology firms.3

The logic of this partition is rooted in the “refundability” of the credit. Small businesses are eligible to receive their certified credit as a refund if it exceeds their tax liability, making the $3.5 million reserve a more liquid and immediate cash infusion.1 Larger firms, meanwhile, must use their share of the $8.5 million to offset existing tax liabilities, with any excess carried forward. The statute includes a “reallocation” provision in § 10-721(c)(5): if small businesses apply for less than $3.5 million in total, the surplus funds flow into the general allocation pool. Conversely, if general applicants do not exhaust the $8.5 million, the remainder can bolster the small business pool.2 In practice, however, both pools are consistently oversubscribed, and such spillovers are rare.1

Defining the “Small Business” Criterion for Allocation

Because the allocation limit is split into two distinct pools, the definition of a “small business” is the single most important factor in determining a company’s competitive landscape for the credit. Maryland uses a specific “Asset Test” rather than traditional metrics like employee headcount or annual revenue.1

The Net Book Value Asset Test

A small business is defined as a for-profit corporation, limited liability company, partnership, or sole proprietorship that possesses “net book value assets” totaling less than $5,000,000.1 This measurement must be taken either at the beginning or the end of the taxable year for which the Maryland qualified research and development expenses are incurred, as reported on the company’s balance sheet.2

The calculation of “Net Book Value” is strictly defined by the Department of Commerce guidance and the statute:

$$Net\ Book\ Value\ Assets = Total\ Assets\ (Including\ Intangibles) – (Depreciation + Amortization)$$

Liabilities are explicitly excluded from this subtraction.1 This means a highly leveraged startup with $10 million in equipment but $9 million in debt would likely not qualify as a small business because its total assets minus depreciation exceed the $5 million threshold, regardless of its net equity. This definition ensures that the $3.5 million set-aside is directed toward truly early-stage or asset-light enterprises, particularly in sectors like software development where intellectual property may not yet be heavily capitalized on the balance sheet.1

Documentation of Small Business Status

To qualify for the $3.5 million allocation and the subsequent benefit of refundability, a firm must provide concrete proof of its asset status. Guidance from the state revenue office requires the attachment of a federal tax return (such as Form 1120, 1065, or 1040) along with a balance sheet that substantiates the net book value claim.1 If the Department determines a firm has exceeded the $5 million threshold, it is moved to the $8.5 million general pool, where it will face different proration pressures and lose the right to a refund.1

Mechanics of the Proration Formula

Proration is the administrative mechanism used to ensure that the total credits awarded stay within the statutory allocation limits. It is a mathematical certainty in the Maryland R&D program, as the state is a hub for high-intensity research in the “I-270 Biotech Corridor” and the “Greater Baltimore” technology ecosystem.1

The Standard Proration Equation

When the total amount of credits applied for by a group (small or non-small) exceeds the allocation for that group, the Department of Commerce applies the following ratio to every individual application:

$$Approved\ Credit = Applied\ Credit \times \frac{Available\ Allocation\ for\ Category}{Total\ Amount\ Applied\ for\ in\ Category}$$

2

For non-small businesses, the fraction is typically $8.5M divided by a much larger number (often $15M or more), while for small businesses, it is $3.5M divided by the total small business demand.2

The Impact of the Individual $250,000 Cap

A secondary limit—the “Individual Applicant Cap”—interacts with the proration formula to further restrict large-scale claims. Under § 10-721(c)(6), the Department may not approve a tax credit for any single applicant in an amount exceeding $250,000 in a single calendar year.2

This creates a “double-capping” effect for the state’s largest R&D spenders. A company that calculates a $1,000,000 growth credit based on 10% of its incremental spend is first subjected to the statewide proration. If the proration rate is 40%, the company’s “tentative” credit becomes $400,000. However, because of the individual cap, the Department must reduce this further to $250,000.2 This redistribution effectively leaves more money in the pool for smaller firms within the same bucket, as the “excess” from the $250,000 cap is not simply lost but is functionally recycled through the proration calculation to benefit other applicants.1

Historical Proration and Oversubscription Statistics

Analyzing the historical subscription levels of the program reveals the significant gap between the 10% statutory rate and the actual economic benefit realized by Maryland firms.

Note: The 2023 figure includes a broader aggregate of credits evaluated by the DLS, but the R&D specific buckets remained oversubscribed following similar trajectories. 6

The Department of Legislative Services (DLS) 2024 evaluation noted that these “unequal credit rates” are an unintentional consequence of administrative procedures.10 Despite legislative attempts to mitigate oversubscription by increasing the cap to $12 million in 2021, the sheer volume of R&D activity in the state—reported at over $1.6 billion in qualified expenses in recent years—continues to outstrip the available tax relief.1

Calculation Methodology: The Maryland Base Amount

To arrive at the “Applied Credit” (the amount before proration), a company must navigate the Maryland Base Amount calculation. Maryland follows the federal incremental methodology but requires the use of Maryland-specific data for both receipts and expenses.1

Maryland Qualified Research Expenses (QREs)

Applicants must first identify their QREs incurred within the State of Maryland. The state adopts the federal definition found in IRC § 41(b), which includes 1:

• In-house Research Expenses: Wages paid to employees directly engaged in research, as well as the immediate supervisors of those employees.
• Supplies: Tangible property (excluding land and depreciable property) used in the conduct of qualified research.
• Contract Research Expenses: 65% of any amount paid to a third party for qualified research performed on the company’s behalf in Maryland.

Calculating Maryland Gross Receipts

The second variable is the average Maryland gross receipts for the four taxable years preceding the credit year.2 Gross receipts are defined as those reasonably attributable to a trade or business in Maryland. If a company is a multi-state operator, it must use an apportionment method consistent with its state income tax filings to determine the “Maryland-source” portion of its total revenue.2

The Fixed-Base Percentage

The fixed-base percentage is determined by dividing the aggregate Maryland QREs for the four taxable years preceding the credit year by the aggregate Maryland gross receipts for those same years.1

$$Fixed\text{-}Base\ \% = \frac{\sum (MD\ QREs_{t-1 \dots t-4})}{\sum (MD\ Gross\ Receipts_{t-1 \dots t-4})}$$

1

For companies that have existed for fewer than four years, the average is based on the years of existence. If the first year of R&D spend is the current year, the fixed-base percentage (and thus the base amount) is $0, allowing the 10% credit to apply to the entire spend.1

Final Base Amount Computation

The Maryland Base Amount is the product of the fixed-base percentage and the average annual Maryland gross receipts for the preceding four years.1

$$MD\ Base\ Amount = Fixed\text{-}Base\ % \times \left( \frac{\sum MD\ Gross\ Receipts_{t-1 \dots t-4}}{4} \right)$$The tentative credit applied for is then:

$$Applied\ Credit = 10\% \times (Current\ MD\ QREs – MD\ Base\ Amount)$$

1

Comprehensive Example: Proration and Allocation in Practice

To illustrate the nuances of the allocation limit and how it affects a firm’s bottom line, consider the case of “AeroDynamics MD,” a mid-sized aerospace engineering firm.

AeroDynamics MD: Year 2024 Financial Profile

• Current Year (2024) Maryland QREs: $4,500,000
• Total Maryland QREs (2020-2023): $12,000,000 (Avg: $3,000,000/year)
• Total Maryland Gross Receipts (2020-2023): $120,000,000 (Avg: $30,000,000/year)
• Net Book Value Assets: $12,500,000 (Classified as a “Non-Small Business”)

Step 1: Base Amount Calculation

First, AeroDynamics calculates its fixed-base percentage:

$$Fixed\text{-}Base\ % = \frac{$12,000,000}{$120,000,000} = 10%$$Next, it calculates the Maryland Base Amount for the 2024 tax year:

$$MD\ Base\ Amount = 10\% \times \$30,000,000 = \$3,000,000$$

Step 2: Tentative Credit Claim

The growth in R&D spend over the base is:

$$\$4,500,000 – \$3,000,000 = \$1,500,000$$

The statutory credit rate is 10%, leading to a tentative claim:

$$Applied\ Credit = 10\% \times \$1,500,000 = \$150,000$$

Step 3: Application of Statewide Allocation Limit

AeroDynamics submits its $150,000 application to the Department of Commerce by the November 15 deadline. In this scenario, let’s assume the non-small business bucket ($8.5 million allocation) receives total applications worth $17,000,000.2

The Department calculates the proration fraction:

$$Fraction = \frac{\$8,500,000}{\$17,000,000} = 0.5\ (or\ 50\%)$$The approved credit for AeroDynamics is:$$\$150,000 \times 0.5 = \$75,000$$

Step 4: Final Certification and Tax Impact

Because $75,000 is well below the $250,000 individual applicant cap, the firm receives a certification letter for $75,000. As a non-small business, AeroDynamics will attach this letter to an amended 2024 Maryland return. If the firm owes $100,000 in state taxes, it will receive a refund check (or reduction in liability) for the $75,000. If it owes only $50,000, it will use $50,000 of the credit and carry the remaining $25,000 forward for up to seven years.1

Revenue Office Guidance and Compliance Requirements

Navigating the Maryland R&D credit requires strict adherence to administrative timelines and documentation standards set forth by both the Department of Commerce and the Comptroller of Maryland.

Mandatory Application and Certification Timeline

The allocation limit necessitates a “wait-and-see” approach for the state. Because the Department cannot know the proration rate until all applications are in, the credit is never claimed on an original return.1

1. Nov 15 (Year T+1): Final deadline for businesses to apply for research conducted in Year T.1
2. Feb 15 (Year T+2): The Department of Commerce completes its proration and issues certification letters to all applicants.1
3. Post-Feb 15: Taxpayers file an amended return for Year T to claim the certified amount.1

Failure to submit the application by November 15 is fatal to the claim. Unlike the federal credit, which can be claimed on an amended return within the general statute of limitations (typically 3 years), the Maryland credit is forfeited if not certified during the specific annual allocation cycle.1

The Role of Controlled Groups

For the purposes of the allocation limit and the $250,000 individual cap, all members of a “controlled group of corporations” (as defined by IRC § 41(f)) are treated as a single taxpayer.1 This is a vital anti-abuse provision. A large conglomerate cannot bypass the $250,000 cap by filing separate applications for ten different subsidiaries. The group must submit a consolidated application, and the single $250,000 limit—and a single proration calculation—will apply to the aggregate spend of the entire group.1

Audit Guidelines and Substantiation

Guidance from the state revenue offices emphasizes that Maryland follows the federal standards for documenting qualified research. To survive an audit, firms must maintain 1:

• Project Documentation: Evidence that the work was intended to create a new or improved “business component” and relied on principles of physical, biological, or computer sciences.
• Proof of Uncertainty: Records showing that at the outset of the project, the capability, method, or design was uncertain.
• Process of Experimentation: Lab notes, testing protocols, trial-and-error logs, and software version histories showing the evaluation of alternatives.
• Employee Time Allocation: Labor time sheets or detailed statistical samplings that tie wage expenses specifically to Maryland-based research activities.

The Impact of the 2025 “One Big Beautiful Bill” Reforms

The tax year 2025 introduced a major variable in R&D planning: the federal “One Big Beautiful Bill Act” (OBBBA), signed on July 4, 2025.17 This federal legislation permanently reinstated the immediate expensing of R&D costs under Section 174, a move that reversed the amortization requirement established by the 2017 Tax Cuts and Jobs Act.17

Maryland’s Automatic Decoupling Mechanism

Maryland is a “rolling conformity” state, meaning it typically adopts federal tax changes as they occur. However, under Maryland Tax-General § 10-108, the state is required to “decouple” from any federal provision that has a fiscal impact of $5 million or more in a single year.20

The Maryland Comptroller’s 60-Day Report, issued on September 5, 2025, confirmed that the federal shift back to R&D expensing would cause a revenue loss of approximately $74.1 million in fiscal 2026.22 Consequently, Maryland has automatically decoupled from this change for the 2025 tax year. This means that while Maryland firms may be able to immediately deduct their R&D expenses on their federal returns, they must continue to capitalize and amortize those same expenses over five years for Maryland state income tax purposes.20

Strategic Implications for the Credit

This decoupling creates a temporary divergence between the federal and state tax bases. While it does not directly change the $12 million allocation limit or the 10% credit rate, it complicates the “net book value asset” test for small businesses.20 Because Maryland taxpayers must maintain a separate amortization schedule for the state, the “book value” of their R&D assets on a Maryland-basis may differ from their federal or GAAP balance sheets. Tax professionals are advised to maintain meticulous “Maryland-only” asset logs to ensure they do not inadvertently lose their “Small Business” status due to the way these capitalized R&D costs are carried on the balance sheet.1

Regional Competition and Comparative Allocations

Maryland’s $12 million allocation limit exists within a competitive regional context. Neighboring states like Pennsylvania also utilize capped R&D incentives, but with different structures. Pennsylvania, for instance, increased its R&D tax credit cap to $60 million for fiscal 2022-23, with a $12 million set-aside for small businesses.24

The relatively small size of Maryland’s $12 million pool, compared to the billions of dollars in R&D performed in the state, results in much stiffer proration than in some other jurisdictions. This has led the Department of Legislative Services to repeatedly evaluate whether the program is meeting its goals or if the high proration is blunting the incentive’s effectiveness.10 The 2024 DLS reevaluation noted that while the credit is highly popular, the concentration of awards among the state’s largest firms remains a point of legislative debate, even with the $250,000 cap in place.10

Conclusion: Navigating the Allocation Frontier

The Maryland R&D Tax Credit is an essential but highly constrained resource for the state’s innovation economy. The “Basic Credit Cap,” as understood through the modern $12 million allocation limit, represents a fundamental compromise between economic stimulus and fiscal discipline. By segregating funds into a $3.5 million small business pool and an $8.5 million general pool, the state provides a pathway for both early-stage startups and mature enterprises to recover costs associated with technical advancement.

However, the reality of the program is defined by its oversubscription. The 10% statutory rate is rarely the actual rate realized by taxpayers; instead, the proration mechanism ensures that the credit remains a shared resource, distributed proportionally across all who apply. For Maryland businesses, success in claiming the credit requires more than just high-quality research; it requires strict adherence to the November 15 application window, precise calculation of the Maryland Base Amount, and a nuanced understanding of how net book value assets dictate their place in the allocation hierarchy. As the program approaches its current sunset in June 2027, and as the state manages the complexities of decoupling from federal reforms, the allocation limit will continue to be the most vital metric for R&D tax planning in the Old Line State.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/